| Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study) (NCT05319990) | University of Colorado, Denver | 2022-03-09 |
| Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy (NCT05418465) | The First Affiliated Hospital of Dalian Medical University | 2022-01-26 |
| A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes (NCT04929379) | Alessandro Doria | 2022-01-04 |
| The Effects of TMZ on Diabetic Nephropathy (NCT05147194) | Tongji Hospital | 2022-01-01 |
| Stem Cell Therapy for Chronic Kidney Disease (NCT04869761) | LaTonya J. Hickson | 2021-10-07 |
| The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD (NCT05656963) | Yipeng Liu | 2021-09-01 |
| Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors (NCT04916132) | Herlev Hospital | 2021-08-10 |
| Prevention In Community Clinics From Diabetic Kidney Disease (NCT04988581) | The First Affiliated Hospital of Xiamen University | 2021-08-01 |
| First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes (NCT04880291) | Goldfinch Bio, Inc. | 2021-05-05 |
| A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease (NCT04750577) | Boehringer Ingelheim | 2021-04-27 |
| Hyperuricemia and Diabetic Nephropathy (NCT04799925) | Assiut University | 2021-04-15 |
| Possible Role of Roflumilast in Diabetic Nephropathy (NCT04755946) | Tanta University | 2021-03-10 |
| MRI Biomarkers in Diabetic Kidney Disease (NCT04570735) | Poitiers University Hospital | 2020-10-07 |
| Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy (NCT04534439) | Aptabio Therapeutics, Inc. | 2020-08-24 |
| A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease (NCT04387448) | Goldfinch Bio, Inc. | 2020-07-28 |
| Niclosamide Role in Diabetic Nephropathy (NCT04317430) | Tanta University | 2020-02-01 |
| Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN) (NCT03933956) | Singapore General Hospital | 2020-01-09 |
| Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance (NCT04074668) | University of Colorado, Denver | 2020-01-01 |
| Uric Acid Lowering Trial in Youth Onset T2D (NCT03899883) | University of Colorado, Denver | 2020-01-01 |
| A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN) (NCT04235621) | Goldfinch Bio, Inc. | 2019-12-20 |
| Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis (NCT03885362) | Imperial College London | 2019-12-11 |
| Use of Wharton Jelly in Diabetic Nephropathy (NCT03288571) | Sophia Al-Adwan | 2019-11-01 |
| Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease (NCT03840343) | Mayo Clinic | 2019-10-23 |
| Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy (NCT04531163) | Al-Azhar University | 2019-10-01 |
| MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus (NCT03945747) | University of Colorado, Denver | 2019-08-14 |
| Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians (NCT04119167) | Chang Gung Memorial Hospital | 2019-08-01 |
| Evaluation of Coffee Therapy for Improvement of Renal Oxygenation (NCT03878277) | University of Colorado, Denver | 2019-07-01 |
| Molecular Analysis of Diabetic Kidney Disease Biopsies (NCT04029402) | Unity Health Toronto | 2019-07-01 |
| Magnesium Supplementation in Diabetic Nephropathy (NCT03824379) | Ain Shams University | 2019-06-01 |
| Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis. (NCT03921216) | Karolinska University Hospital | 2019-04-17 |
| Effects of Fenofibrate Therapy in Diabetic Nephropathy (NCT03869931) | Singapore General Hospital | 2019-03-08 |
| Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic Nephropathy (NCT03820635) | Assiut University | 2019-03-01 |
| Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function (NCT03618420) | University of Colorado, Denver | 2018-10-01 |
| Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes (NCT03620773) | University of Colorado, Denver | 2018-10-01 |
| Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease (NCT03535935) | The University of Hong Kong | 2018-07-01 |
| Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients (NCT03573102) | Nahla H Tohami | 2018-06-20 |
| Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. (NCT03889236) | Leiden University Medical Center | 2018-05-03 |
| Hypomagnesemia and Diabetic Nephropathy (NCT03690180) | Fayoum University | 2018-01-01 |
| This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) (NCT03165227) | Boehringer Ingelheim | 2017-10-17 |
| This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated (NCT03165240) | Boehringer Ingelheim | 2017-10-05 |
| PERL Continuous Glucose Monitoring (CGM) Study (NCT03334318) | Joslin Diabetes Center | 2017-10-01 |
| Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus. (NCT03284996) | Assiut University | 2017-10-01 |
| Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy (NCT03212755) | Assiut University | 2017-08-01 |
| An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes (NCT03216564) | Hamad Medical Corporation | 2017-05-10 |
| Gemigliptin and Biomarkers of Kidney Injury and Vascular Calcification (NCT04705506) | Bangkok Metropolitan Administration Medical College and Vajira Hospital | 2017-02-05 |
| Transformative Research in Diabetic Nephropathy (NCT02986984) | University of Pennsylvania | 2016-12-01 |
| The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. (NCT01320345) | University of Sydney | 2016-11-03 |
| Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy (NCT02690883) | Nanfang Hospital, Southern Medical University | 2016-04-08 |
| PeRsOnalising Treatment Of Diabetic Nephropathy: (NCT03509454) | Peter Rossing | 2016-04-01 |
| Colchicine for Diabetic Nephropathy Trial (NCT02442921) | Sheba Medical Center | 2016-02-22 |
| Renoprotective Effects of Dapagliflozin in Type 2 Diabetes (NCT02682563) | M.H.H. Kramer | 2016-02-01 |
| A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy (NCT02552277) | Celularity Incorporated | 2015-10-27 |
| Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease (NCT02515461) | Odense University Hospital | 2015-07-01 |
| Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy (NCT02488252) | The University of Hong Kong | 2015-07-01 |
| Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy (NCT03006952) | Tehran University of Medical Sciences | 2015-04-01 |
| Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL) (NCT02410005) | Weill Cornell Medical College in Qatar | 2014-10-01 |
| Measurement of Endothelial Function and Cardiac Output: New Methods (NCT02299960) | Charite University, Berlin, Germany | 2014-08-01 |
| Arterial Stiffness and Complication Risk in Type 2 Diabetes (NCT02001532) | Aarhus University Hospital | 2014-05-01 |
| Metabolomic Profiling in Adolescents With Obesity and Diabetes (NCT02145572) | University of California, San Diego | 2014-05-01 |
| To Explore the Anti-oxidative Effects and Inflammation Effects of Soy Protein to Renal Function of End Stage Diabetes Nephropathy Patients (NCT05840796) | Taipei Medical University | 2014-04-01 |
| A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes (NCT02017171) | Alessandro Doria | 2014-02-01 |
| The Hong Kong Diabetes Biobank (NCT05282680) | Chinese University of Hong Kong | 2014-02-01 |
| Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy (NCT03137316) | Benha University | 2014-01-01 |
| Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) (NCT01968668) | Bayer | 2013-10-28 |
| Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease (NCT01094769) | Baker Heart and Diabetes Institute | 2011-04-01 |
| N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy (NCT00915200) | The University of Texas Health Science Center at San Antonio | 2009-10-01 |
| Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients (NCT00713011) | Bayer | 2008-11-01 |
| Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant (NCT00446251) | University of Washington | 2006-12-01 |
| Comprehensive Management of Diabetic Patients With Renal Impairment : Impact on Blood Pressure and Glycemic Control (NCT00306436) | University Hospital, Bordeaux | 2006-05-01 |
| Glucose in Dialysis Water in Diabetics With Chronic Renal Failure (NCT00438503) | Regional Hospital Holstebro | 2006-05-01 |
| Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy (NCT00237952) | Chang Gung Memorial Hospital | 2005-08-01 |
| The Effect of Folic Acid Administration in the Progression of Microalbuminuria (NCT00737126) | Hospital Universitario Dr. Jose E. Gonzalez | 2004-01-01 |
| A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) (NCT00168857) | Boehringer Ingelheim | 2003-07-09 |
| INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy (NCT00153088) | Boehringer Ingelheim | 2003-01-01 |
| Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy (NCT00448526) | Kanazawa Medical University | 1997-12-01 |